Skip to content

NBP

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$1.30
+3.17%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-24.4%
Return on equity
-21.2%
Return on assets
-29.2%
Return on invested capital
0.00x
Asset turnover
-$34.3M
Cash from operations
$1.65
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026